How Prominent Is The Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Grow?
The methicillin-resistant staphylococcus aureus (MRSA) drugs market size has grown steadily in recent years, amplifying from $2.35 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. This momentum during the historic period can be attributed to rising antibiotic resistance, an increase in hospital-acquired infections, surgical procedures, a global uptick in MRSA cases and high mortality rates.
The MRSA drugs market size is expected to witness robust growth in the next few years, poised to escalate to $3.09 billion in 2029 at a CAGR of 5.8%. Drivers for this potent growth during the forecast period include continued antibiotic resistance hurdles, advancements in MRSA diagnostics, global healthcare-associated infections, preventive measures in surgery, and rising community-acquired MRSA cases. A significant trend in the forecast period involves the focus on immunomodulators, strategic partnerships for drug development and customized therapies based on strain characteristics.
Get Your Free Sample of The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10859&type=smp
What Are Factors Driving the Growth of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market?
Rising Hospital-Acquired Infections (HAIs) are expected to foster the growth of the MRSA drugs market. Such infections, attributed to factors like contaminated medical equipment, poor hand hygiene among healthcare staff, overuse of antibiotics, prolonged hospital stays, and weakened patient immune systems, often occur 48 hours or more after admission. MRSA drugs help treat these infections by targeting and inhibiting MRSA strains that are resistant to standard antibiotics, thereby reducing the spread and severity of these infections in healthcare settings. The World Health Organisation reported an estimated 136 million cases of health care-associated antibiotic-resistant infections globally every year in 2023. This rise in the prevalence of MRSA infections drives the growth of the MRSA drugs market.
What Are the Different Segments Within the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market?
– By Drug Class: Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, Lipoglycopeptide, Other Drug Classes
– By Indication: Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections
– By MRSA Type: Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)
– By Route of Administration: Oral Administration, Parenteral Administration
– By End User: Hospitals and Clinics, Research and Academic Institutes, Other End-Users
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-global-market-report
Which are the Major Companies Operating in the MRSA Drugs Market?
Key players in this industry include Basilea Pharmaceutica Ltd., Merck & Co Inc., Pfizer Inc., Theravance Biopharma Inc., Allergan plc, Cumberland Pharmaceuticals Inc., Debiopharm International S.A., AbbVie Inc., Innovation Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc, Paratek Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., AmpliPhi Biosciences Corporation, AstraZeneca plc, Meiji Seika Kaisha Ltd., GlaxoSmithKline plc, Johnson & Johnson, Sanofi S.A., Novartis, Wockhardt, Sun Pharmaceutical Industries Ltd., Lupin Limited, Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, Astellas Pharma Inc.
What Are Your Future Expectations Of The MRSA Drugs Market?
Product innovation is set to drive growth in the MRSA drugs market. Companies are focusing on creating new products to sustain their position in the market. For instance, in March 2023, Endo, a US-based biopharmaceutical firm, launched the generic version of Pylera, offering a cost-efficient treatment option for patients suffering from Helicobacter pylori infections.
Which Region Is Projected To Be The Fastest-Growing In The MRSA Drugs Market?
North America was the largest region in the global MRSA drugs market in 2024, followed by Asia-Pacific which is expected to be the fastest-growing in the forecast period. Major regions covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Report 2025 Offer?
Methicillin-resistant Staphylococcus aureus (MRSA) drugs refer to a group of drugs used to treat infections caused by the bacterium Staphylococcus aureus that are resistant to methicillin and other common antibiotics. These drugs specifically target and kill MRSA bacteria or inhibit their growth. MRSA is a source of staph infections that is challenging to treat due to antibiotic resistance. The Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10859
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
